PRAXOLE XR pramipexole dihydrochloride monohydrate 2.25 mg modified release tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

pramipexole dihydrochloride monohydrate, Quantity: 2.25 mg

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

pramipexole dihydrochloride monohydrate

Zāļu forma:

Tablet, modified release

Kompozīcija:

Excipient Ingredients: hypromellose; magnesium stearate; silicon dioxide; calcium hydrogen phosphate

Ievadīšanas:

Oral

Vienības iepakojumā:

30, 10

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

For the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

Produktu pārskats:

Visual Identification: White or nearly white, cylindrical and biconvex tablets marked with 157 on one side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorizācija statuss:

Licence status A

Autorizācija datums:

2015-06-17